Z-138Homo sapiens (Human)Cancer cell line

Also known as: Z138

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_B077
SpeciesHomo sapiens (Human)
Tissue SourceBone marrow[UBERON:UBERON_0002371]

Donor Information

Age70
Age CategoryAdult
SexMale

Disease Information

DiseaseMantle cell lymphoma
LineageLymphoid
SubtypeMantle Cell Lymphoma
OncoTree CodeMCL

DepMap Information

Source TypeATCC
Source IDACH-002500_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTRAF2p.Trp114Ter (c.341G>A)Unspecified-PubMed=24362935

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
10,11
D13S317
9,12
D16S539
11
D18S51
14,18
D19S433
12,14
D21S11
30,32.2
D2S1338
19
D3S1358
16
D5S818
11,13
D7S820
8
D8S1179
8,13
FGA
20,22
Penta D
13,15
Penta E
7,18
TH01
6
TPOX
8
vWA
15,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Strategic therapeutic targeting to overcome venetoclax resistance in aggressive B-cell lymphomas.

Medeiros L.J., Ford R.J. Jr., Nomie K., Zhang L., Wang M.

Clin. Cancer Res. 24:3967-3980(2018).

Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma.

Touzeau C., Le Gouill S., Amiot M., Pellat-Deceunynck C.

Blood 128:2808-2818(2016).

Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma.

Isik E., Letai A.G., Lossos I.S.

Blood 126:1555-1564(2015).

A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines.

Boegel S., Lower M., Bukur T., Sahin U., Castle J.C.

OncoImmunology 3:e954893.1-e954893.12(2014).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines.

Moreau-Aubry A., Amiot M., Pellat-Deceunynck C.

Cytometry A 87:285-288(2015).

Development and characterization of a Mantle Cell Lymphoma Cell Bank in the American Type Culture Collection.

O'Connor O.A.

Leuk. Lymphoma 56:2114-2122(2015).

Pharmacological and genomic profiling identifies NF-kappaB-targeted treatment strategies for mantle cell lymphoma.

Lenz G., Stegmeier F.

Nat. Med. 20:87-92(2014).

A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.

Martinez-Climent J.A.

Proc. Natl. Acad. Sci. U.S.A. 108:12461-12466(2011).

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.

Martinez-Climent J.A.

Blood 109:271-280(2007).

Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma.

Medeiros L.J., Estrov Z., Rassidakis G.Z.

Leuk. Res. 30:497-501(2006).

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of mantle cell lymphoma.

Williams M.E.

Leuk. Res. 30:449-457(2006).

Z-138: a new mature B-cell acute lymphoblastic leukemia cell line from a patient with transformed chronic lymphocytic leukemia.

Hirsch-Ginsberg C.F., Huh Y.O., Yee G., Kurzrock R.

Leuk. Res. 22:341-353(1998).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).